ARCHIVES

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

FDA Approves Afinitor Tablets For Advanced Breast Cancer

August 31, 2012

Community Oncology Program Proves Technology Transfer Can Work; Survival Improvement Shown

March 21, 1980

In Brief: Baltimore Resigns as Rockefeller President; Perry Named Medical Director At Ellis Fischel

December 13, 1991

Obituary: Joan Mauer, 65, Chief, NCI Clinical Trials Monitoring Branch

October 15, 2010

Fischinger Names HHS AIDs Coordinator; DeVita Appoints Maryann Roper Acting Deputy Director

October 30, 1987

ACCC Seeks Expanded Backing For CHOP, Other Community Cancer Programs

November 7, 1980